Oct. 21st 9:35-10:10
Predicting the Crystallization Propensity of Active Pharmaceutical Ingredients
Bruno C. Hancock currently leads the global pharmaceutical materials science group at Pfizer Inc. At Pfizer, he has worked in the areas of formulation development (focused on spray-dried dispersions), powder technology, pharmaceutical materials science, drug product process development & technology transfer, and computational drug product design. Bruno has published over one hundred-and-thirty full research papers and a dozen patents. He was elected to Fellow status in the American Association of Pharmaceutical Scientists in 2004, and he has been an Editor for the Journal of Pharmaceutical Sciences since 2014.